Leadership & Staff
-
Rita Balice-Gordon, PhD
Global Head, Rare and Neurologic Diseases Therapeutic Area
Sanofi, Inc. -
Bastiaan R. Bloem, MD, PhD
Consultant Neurologist
Radboud University Medical Centre -
Patrik Brundin, MD, PhD
Associate Director of Research, Professor and Director of the Center for Neurodegenerative Science and Jay Van Andel Endowed Chair in Parkinson’s Research
Van Andel Institute -
Carole Ho, MD
Chief Medical Officer and Head of Development
Denali Therapeutics -
Jeffrey H. Kordower, PhD
The Jean Schweppe-Armour Professor of Neurological Sciences and Professor of Neurosurgery
Rush University Medical Center -
Kenneth L. Marek, MD
President and Senior Scientist
The Institute for Neurodegenerative Disorders -
Soania Mathur, MD
Co-Chair
Ontario, Canada -
Kalpana M. Merchant, PhD
President and CSO
TransThera Consulting Co. -
Brit Mollenhauer, MD
Assistant Professor and Attending Physician
University Medical Center of Goettingen -
Ian J. Reynolds, PhD
Chief Executive Officer
Rewind Therapeutics -
Eric Siemers, MD
Consultant -
D. James Surmeier, PhD
Professor and Chair of the Department of Physiology at the Feinberg School of Medicine and Director of the Morris K. Udall Research Center of Research Excellence for Parkinson's Disease
Northwestern University -
Andrew West, PhD
Professor of Pharmacology and Neurology
Duke University